|Articles|March 17, 2003
HSE P&T Portfolio: Humira
Adalimumab(Humira)for use in adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more disease-modifying antirheumatic drugs.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Addressing Depression Symptoms Can Significantly Improve Asthma Outcomes
2
President Trump Signs Sweeping, Unprecedented Federal PBM Reform
3
TrumpRx Officially Launches, Introduces Drug Prices
4
Q&A: PBMs, Community Pharmacy’s Next Move Following PBM Reform Signing
5



















